Loss of the Y chromosome barely alters tumour gene activity
Analyses of human kidney tumours, mice and cell lines showed that losing the Y chromosome produces few broad changes in gene activity across cancers.
Mice
Using observational data from two human cohorts with clear cell renal cell carcinoma, alongside experiments in a mouse model of the disease and cultured human kidney cancer cells, researchers analysed tumour gene activity. Across all three settings, loss of the Y chromosome mostly changed the activity of genes on the sex chromosomes themselves, matching their lost copies. It produced no large effects on other chromosomes. In the human cohorts, tumours lacking the Y chromosome showed modest shifts in pathways linked to cell division, protein-making machinery and DNA repair. A wider analysis across other tumour types found the same pattern, though some non-kidney cancers had higher expression of cancer/testis antigens. The authors concluded that Y chromosome loss is largely silent in gene activity across cancers.
Why it matters
Tumours in men often lose the Y chromosome, which predicts poor outcomes in some cancers. Clarifying whether this loss alters wider gene activity bears on how sex-specific chromosome changes contribute to tumour development in adults.
Caveats
The human findings come from observational tumour cohorts, and the cell experiments used clones from a single cell line. The paper is also a preprint that has not yet been peer-reviewed.
The paper
Show 8 more authors
F. Cuomo, M. Adlesic, L. Nguekeu Zebaze, C. Witt, Z. Rodriguez Hernandez, A. Koettgen, M. Boerries, P. Schlosser,Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, G
bioRxiv, 9 Oct 2026, CC BY, Preprint, not peer-reviewed